These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6221999)

  • 21. Activation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast.
    Kozel TR; Pfrommer GS
    Infect Immun; 1986 Apr; 52(1):1-5. PubMed ID: 3514450
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythrocyte enhancement of C3b-mediated phagocytosis by human neutrophils in vitro: a combined effect of the erythrocyte complement receptors CR1 and erythrocyte scavengers to reactive oxygen metabolites (ROM).
    Forslid J; Hed J; Stendahl O
    Immunology; 1985 May; 55(1):97-103. PubMed ID: 3158597
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Common binding region of complement factors B, H and CR1 on C3b revealed by monoclonal anti-C3d.
    Koistinen V; Wessberg S; Leikola J
    Complement Inflamm; 1989; 6(4):270-80. PubMed ID: 2527715
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Binding of activated C3b component with complement effector].
    Kozlov LV; Rostovtseva LI; Lomaka TS; Sutovskaia NS
    Bioorg Khim; 1985 Jun; 11(6):762-8. PubMed ID: 3849970
    [TBL] [Abstract][Full Text] [Related]  

  • 25. C3 modified at the thiolester site: acquisition of reactivity with cellular C3b receptors.
    Schreiber RD; Pangburn MK; Müller-Eberhard HJ
    Biosci Rep; 1981 Nov; 1(11):873-80. PubMed ID: 6458338
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reactivity of purified complement component 3b with bovine neutrophils and modulation of complement receptor 1.
    Di Carlo AL; Paape MJ; Miller RH
    Am J Vet Res; 1996 Feb; 57(2):151-6. PubMed ID: 8633799
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development and application of an enzyme-linked immunosorbent assay for the quantitation of alternative complement pathway activation in human serum.
    Mayes JT; Schreiber RD; Cooper NR
    J Clin Invest; 1984 Jan; 73(1):160-70. PubMed ID: 6418767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Studies on the binding of C3b-coated microspheres to human neutrophils.
    Ogle JD; Ogle CK; Noel JG; Hurtubise P; Alexander JW
    J Immunol Methods; 1985 Jan; 76(1):47-62. PubMed ID: 3155777
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ligand binding specificity of a rabbit alveolar macrophage receptor for C3b.
    Dixit R; Schneider R; Law SK; Kulczycki A; Atkinson JP
    J Biol Chem; 1982 Feb; 257(4):1595-7. PubMed ID: 6460027
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neutrophils express a receptor for iC3b, C3dg, and C3d that is distinct from CR1, CR2, and CR3.
    Vik DP; Fearon DT
    J Immunol; 1985 Apr; 134(4):2571-9. PubMed ID: 3156185
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Role of binding through C3b and IgG in polymorphonuclear neutrophil function: studies with trypsin-generated C3b.
    Newman SL; Johnston RB
    J Immunol; 1979 Oct; 123(4):1839-46. PubMed ID: 573303
    [No Abstract]   [Full Text] [Related]  

  • 32. Interaction of vaccinia virus complement control protein with human complement proteins: factor I-mediated degradation of C3b to iC3b1 inactivates the alternative complement pathway.
    Sahu A; Isaacs SN; Soulika AM; Lambris JD
    J Immunol; 1998 Jun; 160(11):5596-604. PubMed ID: 9605165
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Physiologic inactivation of fluid phase C3b: isolation and structural analysis of C3c, C3d,g (alpha 2D), and C3g.
    Davis AE; Harrison RA; Lachmann PJ
    J Immunol; 1984 Apr; 132(4):1960-6. PubMed ID: 6607952
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cleavage of membrane bound C3bi, an intermediate of the third component of complement, to C3c and C3d-like fragments by crude leucocyte lysosomal lysates and purified leucocyte elastase.
    Carlo JR; Spitznagel JK; Studer EJ; Conrad DH; Ruddy S
    Immunology; 1981 Oct; 44(2):381-91. PubMed ID: 7028603
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of complement receptor type three and serum opsonins in the neutrophil response to yeast.
    Cain JA; Newman SL; Ross GD
    Complement; 1987; 4(2):75-86. PubMed ID: 3040333
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Membrane complement receptor type three (CR3) has lectin-like properties analogous to bovine conglutinin as functions as a receptor for zymosan and rabbit erythrocytes as well as a receptor for iC3b.
    Ross GD; Cain JA; Lachmann PJ
    J Immunol; 1985 May; 134(5):3307-15. PubMed ID: 2984286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of antigen site and complement receptor status on the rate of cleavage of C3c antigen from red cell bound C3b.
    Currie MS; Rustagi PK; Wojcieszak R; Ziolkowski L; Ross GD; Logue GL
    Blood; 1988 Mar; 71(3):786-90. PubMed ID: 3345346
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Third component of human complement: C3.
    Berger M
    Methods Enzymol; 1990; 184():619-28. PubMed ID: 2143801
    [No Abstract]   [Full Text] [Related]  

  • 39. Membrane sialic acid on target particles modulates their phagocytosis by a trypsin-sensitive mechanism on human monocytes.
    Czop JK; Fearon DT; Austen KF
    Proc Natl Acad Sci U S A; 1978 Aug; 75(8):3831-5. PubMed ID: 278997
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inefficient binding of IgM immune complexes to erythrocyte C3b-C4b receptors (CR1) and weak incorporation of C3b-iC3b into the complexes.
    Kávai M; Rasmussen JM; Baatrup G; Zsindely A; Svehag SE
    Scand J Immunol; 1988 Jul; 28(1):123-8. PubMed ID: 2969612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.